Resources
Meet us at the next conference or check out our latest projects
Home > Resources
From the Team
Meet us at SfN - Booth 3026
November 15-19 2025 in San Diego!
We are excited to share that we will be at SfN this year, presenting our advanced electrophysiology solutions for pharmaceutical development and clinical applications. Our team will showcase how the Lucerum platform delivers qEEG, source localization, and connectomics to accelerate discovery and bring precision neuroscience into clinical practice.
Lucerum and EGI Join Forces to Advance EEG in Clinical Trials
Lucerum and EGI have partnered to deliver complete EEG solutions for clinical trial EEG with on site data collections and fast analytics.
HD-EEG modalities are fully integrated with Lucerum’s neuroanalytics platforms, spanning translational pharmaco-EEG, source-localized tomography, neuroplastogen connectomics, and AI-ready biomarker pipelines.
emka TECHNOLOGIES - Lucerum
Partnership to Streamline Preclinical Telemetry Data Analyses
emka TECHNOLOGIES is partnering with Lucerum, Inc. to deliver an integrated solution for preclinical telemety data analytics, providing end-to-end workflows fom high-quality data acquisition with emka systems to advanced multimodal signal analysis integrated with LucerumKey.
New Capability: Neurotransmitter Predictions
Relating Neural Oscillations to Neurotransmitter Dominance
To relate neurotransmitter or transporter contribution to changes in neural oscillations due to a drug or therapeutic intervention, we use models which predict the cortical power distribution of each EEG frequency band using normative PET or autoradiography-derived neurotransmitter cortical densities and normative EEG databases. We then apply dominance analyses to identify the neurotransmitters that contributed most to the fit (e.g., comparing before and after treatment). The differences between conditions highlight changes in NT dominance which provide powerful insight into the target.
